In hospitalized patients with COVID-19, the routine use of molecular point-of-care testing in emergency department admissions was associated with a large reduction in time to results compared with laboratory PCR testing.
The use of CPAP alone does not appear to improve hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease and obstructive sleep apnea.
Female candidates for liver transplant who have portopulmonary hypertension have higher pulmonary vascular resistance, lower Model for End-Stage Liver Disease scores, and are more likely to have autoimmune liver disease, compared with male candidates.
The use of intensive lifestyle intervention for weight loss in patients with type 2 diabetes has been shown to reduce the overall severity of obstructive sleep apnea.
